Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, TDS, TRI

Alligator Bioscience to Present at the 10th Annual Biotech Showcase Conference


LUND, Sweden, Jan. 4, 2018 /PRNewswire/ --

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing tumor-directed immunotherapies, today announced that the company is scheduled to present at the 10th Annual Biotech Showcase conference held 8-10 January, 2018 in San Francisco, US.

Chief Executive Officer Per Norlén will give an update on the company's clinical stage project ADC-1013, out-licensed to Janssen Biotech Inc., as well as the near-clinical bispecific antibody ATOR-1015 and the preclinical projects ALG.APV-527 and ATOR-1017.

The presentation will take place on 8 January, at 10:30 a.m. PST /8 Jan 7:30 p.m. CET. The audio and slide presentation will be webcasted live and can be accessed via the Alligator web site. To access the presentation, live and replay, please go to https://event.webcasts.com/starthere.jsp?ei=1175723&tp_key=101995f0f8.

The information was submitted for publication, through the agency of the contact person set out above, at 11:00 a.m. CET on 4 January 2018.

About Alligator Bioscience
Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immunotherapies. Alligator's growing pipeline includes four lead clinical and pre-clinical therapeutic antibodies (ADC-1013, ATOR-1015, ATOR-1017 and ALG.APV-527). ADC-1013 (JNJ-64457107) is licensed to Janssen Biotech, Inc., part of J&J, for global development and commercialization. Alligator's shares are listed on Nasdaq Stockholm (ATORX). The Company is headquartered in Lund, Sweden, and has approximately 50 employees. For more information, please visit www.alligatorbioscience.com.

For further information, please contact:
Cecilia Hofvander,
Director Investor Relations & Communications
Phone +46-46-286-44-95
E-mail: [email protected]

This information was brought to you by Cision http://news.cision.com
http://news.cision.com/alligator-bioscience/r/alligator-bioscience-to-present-at-the-10th-annual-biotech-showcase-conference,c2425257

The following files are available for download:

http://mb.cision.com/Main/12681/2425257/773833.pdf

Alligator Bioscience to Present at the 10th Annual Biotech Showcase Conference

 


These press releases may also interest you

at 19:22
SK hynix Inc. (or "the company", www.skhynix.com) announced today that it recorded 12.43 trillion won in revenues, 2.886 trillion won in operating...

at 19:02
Arizona Governor Katie Hobbs, Arizona Corporation Commission (ACC) Commissioner Lea Marquez Peterson, and executives from Arizona Public Service (APS), Longroad Energy (Longroad), McCarthy Building Companies (McCarthy), and U.S. Bancorp Impact...

at 19:00
Terra Drone Corporation, a leading drone and Advanced Air Mobility (AAM) technology provider headquartered in Japan, announced today the launch of joint development with its Group companies Unifly NV ("Unifly") and Aloft Technologies Inc. ("Aloft")...

at 19:00
Terra Drone Corporation, a leading drone and Advanced Air Mobility (AAM) technology provider headquartered in Japan, has announced the launch of joint development with its Group companies Unifly NV ("Unifly") and Aloft Technologies Inc. ("Aloft")...

at 18:55
Orion Group ("Orion"), a commercial and industrial field services company backed by Alpine Investors ("Alpine"), announced today that it has partnered with Academy Locksmith ("Academy"). Academy provides mechanical and electronic locksmithing, door,...

at 18:30
St. Joseph's Hospital today announced that it becomes the first health care facility to use checkout-free technology in a hospital cafeteria, demonstrating BayCare and St. Joseph's Hospital's commitment to innovation, patient care and team member...



News published on and distributed by: